Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pelubiprofen controlled released tablet for acute traumatic injury is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Injury

Drugs mentioned

• Pelubiprofen controlled released tablet (pelubiprofen)

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Acute Traumatic Injury | Phase 3 | Status: UNKNOWN